Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) issued an announcement. All prerequisites of the subscription agreement have been met, and the subscription matters were completed on August 12, 2026. A total of 2,435,600 subscribed shares (accounting for approximately 2.17% of the number of shares issued immediately after completion) have been allocated and issued to the subscribers at the subscription price of HK$4.69 per subscription share in accordance with the terms and conditions of the subscription agreement. The net proceeds from the subscription process were approximately HK$11.3 million. The Group intends to use the proceeds from the subscription process as its general working capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.